Profound Medical Corp. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Profound Medical Corp. on April 16, 2026. The filing serves as a Regulation FD disclosure to announce the upcoming release of the Company's first quarter 2026 financial results.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural announcement regarding the timing of future financial reporting rather than a financial statement itself.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document solely confirms the schedule for the upcoming earnings release.
Guidance, Outlook, and Management Commentary
- Earnings Release Date: The Company plans to release its first quarter 2026 financial results after market close on Thursday, May 7, 2026.
- Conference Call: A conference call to review results and discuss business developments is scheduled for 4:30 p.m. Eastern Time on May 7, 2026.
- Access Information: Details on accessing the conference call and webcast are contained in the press release furnished as Exhibit 99.1.
Investor Verification Checklist
- Verify the exact time and date of the Q1 2026 earnings release (May 7, 2026, after market close).
- Confirm the conference call dial-in details and webcast link via the press release (Exhibit 99.1).
- Note that the information in this 8-K is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other SEC filings.